The Ethicon SURGICEL™ SNoW 5.1 × 10.2 cm Absorbable Hemostat (2092) is a sterile haemostatic agent composed of oxidised regenerated cellulose (ORC) in a structured non-woven fabric format. Designed for adjunctive haemostasis, SNoW assists in the control of capillary, venous and small arterial haemorrhage when conventional methods such as ligation or cautery are impractical or ineffective.

The structured non-woven design enhances conformability and surface contact, allowing the material to adapt effectively to irregular or difficult-to-access bleeding sites. This format provides improved handling and tissue adherence compared to traditional knitted haemostats.

Upon contact with blood, SURGICEL™ SNoW forms a gelatinous mass that provides a matrix for platelet adhesion and aggregation, facilitating clot formation. The material is fully absorbable and gradually resorbed by the body during healing.

The 5.1 × 10.2 cm size provides expanded coverage for moderate surgical fields requiring reliable haemostatic support. Supplied sterile and ready to use directly from the package, product code 2092 is intended for professional surgical use and should be stored at controlled room temperature (15°–30°C).

• Key Features
• • Oxidised regenerated cellulose haemostat
• • Structured non-woven SNoW format
• • 5.1 × 10.2 cm size
• • Enhanced conformability to tissue surfaces
• • Suitable for difficult-to-access bleeding sites
• • Assists control of capillary, venous and small arterial bleeding
• • Fully absorbable material
• • Sterile, single-use — Box of 5
• Technical Specifications
• Brand: Ethicon
• Product Code: 2092
• Product Name: SURGICEL™ SNoW
• Material: Oxidised Regenerated Cellulose (Structured Non-Woven)
• Form: Non-Woven Fabric Hemostat
• Absorbability: Absorbable
• Size: 5.1 × 10.2 cm
• Bleeding Situation: Difficult to Access
• Preparation: Ready out of package
• Storage: 15°–30°C (59°–86°F)
• Packaging: Box of 5
• Category: Adjunctive Hemostat
• Indications for Use
• • Control of capillary bleeding
• • Control of venous bleeding
• • Control of small arterial haemorrhage
• • Adjunctive haemostasis in confined surgical sites
• • Difficult-to-access operative fields